Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand | MicrobiomeTrials← Back to trialsNCT07082465
Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-08-01Est. Completion: 2026-08-16
Enrollment target: 108,000 participants Locations- Chiangrai Prachanukroh Hospital, Chiang Rai, Chiangrai, Thailand
- Phrachomklao Hospital, Phetchaburi, Thailand
- Chaoprayayommarat Hospital, Suphan Buri, Thailand
- Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand
Other microbiome trials you might be interested in
End-Stage Renal DiseaseHemodialysis Complication
This randomized, assessor-blinded controlled trial will evaluate the preliminary efficacy and safety of a 12-week superv…
Isfahan, IranEst. completion Oct 2026
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell Carcinoma
Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma
Locally Recurrent Laryngeal Squamous Cell Carcinoma
Locally Recurrent Oral Cavity Squamous Cell Carcinoma
Locally Recurrent Oropharyngeal Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell Carcinoma
Metastatic Hypopharyngeal Squamous Cell Carcinoma
Metastatic Laryngeal Squamous Cell Carcinoma
Metastatic Melanoma
Metastatic Oral Cavity Squamous Cell Carcinoma
Metastatic Oropharyngeal Squamous Cell Carcinoma
Recurrent Melanoma
Stage III Hypopharyngeal Carcinoma AJCC v8
Stage III Laryngeal Cancer AJCC v8
Stage III Lip and Oral Cavity Cancer AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IV Hypopharyngeal Carcinoma AJCC v8
Stage IV Laryngeal Cancer AJCC v8
Stage IV Lip and Oral Cavity Cancer AJCC v8
Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Unresectable Melanoma
This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in tr…
Phoenix, United StatesEst. completion Jan 1, 2027
Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)OverweightMetabolic Syndrome
The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control a…
Almaty, KazakhstanEst. completion Nov 2026